NMR-based urine analysis followed by multivariate data analysis (metabonomics)
identifies efficiently differences between toxic and non-toxic compounds; but in most cases
multiple administrations of the test compound are necessary. We tested the feasibility of
detecting proximal tubule kidney toxicity and phospholipidosis with metabonomics
techniques after single compound administration as an early safety pharmacology approach